{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-218056","form_type":"8-K","ticker":"VIVS","cik":"0001497253","company_name":"VivoSim Labs, INC.","filed_at":"2023-08-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.092165+00:00","generated_at":"2026-06-11T05:35:37.394195+00:00","sec_items":["2.05","5.02","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Organovo reduces workforce by 24% and terminates General Counsel and CSO to focus on FXR314","bullets":["Workforce reduced by ~6 employees (~24% of staff) effective Aug 25, 2023 to focus on clinical drug FXR314.","Tom Jurgensen (General Counsel & Corporate Secretary) and Jeffrey Miner (CSO) terminated; last day Aug 25, 2023.","Company expects to enter consulting agreement with Dr. Miner for post-termination services.","Severance charges not yet estimable; will amend filing once determined."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-218056","json":"https://secwatch.observer/filing/0001193125-23-218056.json","markdown":"https://secwatch.observer/filing/0001193125-23-218056.md","text":"https://secwatch.observer/filing/0001193125-23-218056.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1497253/000119312523218056/0001193125-23-218056-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1497253/000119312523218056/d434452d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T05:35:37.394195+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"087c02b755","claim":"Tom Jurgensen was terminated as General Counsel and Corporate Secretary at VivoSim Labs, INC..","evidence_excerpt":"on August 16, 2023, Tom Jurgensen, the Company’s General Counsel and Corporate Secretary, and Jeffrey Miner, the Company’s Chief Scientific Officer, were each notified that his employment with the Company would be terminated.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1497253/000119312523218056/0001193125-23-218056-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"General Counsel and Corporate Secretary"}],"fact_type":"executive_change"},{"claim_id":"cc3a034411","claim":"Jeffrey Miner was terminated as Chief Scientific Officer at VivoSim Labs, INC..","evidence_excerpt":"on August 16, 2023, Tom Jurgensen, the Company’s General Counsel and Corporate Secretary, and Jeffrey Miner, the Company’s Chief Scientific Officer, were each notified that his employment with the Company would be terminated.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1497253/000119312523218056/0001193125-23-218056-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Chief Scientific Officer"}],"fact_type":"executive_change"},{"claim_id":"5ccff88da4dfb1074b1cf094d075d7570741e615","claim":"VivoSim Labs, INC. announced a restructuring (approximately six employees, which represents approximately 24% of its employees as of August 18, 2023).","evidence_excerpt":"On August 18, 2023, Organovo Holdings, Inc. (the “Company”) announced to its employees a plan to reduce the Company’s workforce, effective August 25, 2023, by approximately six employees, which represents approximately 24% of its employees as of August 18, 2023.","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1497253/000119312523218056/0001193125-23-218056-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Headcount","value":"approximately six employees, which represents approximately 24% of its employees as of August 18, 2023"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}